Q1 2021 Holdings
Filed 2021-05-14 | 111 holdings | $789.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $237.7M | 1,683,362 | 30.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $107.3M | 1,622,799 | 13.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $91.5M | 1,616,497 | 11.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $80.5M | 3,908,947 | 10.2% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $79.4M | 2,149,228 | 10.1% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $54.7M | 799,009 | 6.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $46.5M | 2,000,000 | 5.9% |
| Apyx Medical Corporation(APYX) | COM | 03837C106 | $32.8M | 3,391,279 | 4.1% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $19.9M | 5,978,355 | 2.5% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $11.9M | 1,533,758 | 1.5% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $8.7M | 31,752 | 1.1% |
| Acutus Med Inc(AFIB) | COM | 005111109 | $6.0M | 451,834 | 0.8% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $5.6M | 280,000 | 0.7% |
| Aziyo Biologics Inc(ELUT) | COM CL A | 05479K106 | $1.7M | 125,000 | 0.2% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $697.3K | 15,715,286 | 0.1% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $375.0K | 946,255 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $251.0K | 4,517,570 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $250.7K | 5,293,966 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $228.4K | 1,333,232 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $190.8K | 7,463,291 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $185.1K | 481,956 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $173.9K | 1,712,234 | 0.0% |
| DermTech Inc(DMTKQ) | COM | 24984K105 | $158.4K | 3,118,665 | 0.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $145.0K | 2,319,138 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $141.5K | 3,644,248 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $136.6K | 594,956 | 0.0% |
| 10x Genomics Inc(TXG) | CL A COM | 88025U109 | $128.8K | 711,515 | 0.0% |
| Cerner Corp(CERNCHF) | COM | 156782104 | $127.6K | 1,774,485 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $112.8K | 1,883,864 | 0.0% |
| Quidel Corp | COM | 74838J101 | $112.4K | 878,533 | 0.0% |
| Globus Med Inc(GMED) | CL A | 379577208 | $103.0K | 1,670,811 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $102.0K | 6,356,743 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $100.5K | 1,139,230 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $94.4K | 2,762,791 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $93.1K | 609,774 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $90.8K | 3,507,390 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $87.1K | 3,995,000 | 0.0% |
| Tarsus Pharmaceuticals Inc.(TARS) | COM | 87650L103 | $79.1K | 2,463,601 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $72.5K | 7,348,976 | 0.0% |
| Translate Bio Inc | COM | 89374L104 | $72.3K | 4,382,199 | 0.0% |
| MacroGenics Inc(MGNX) | COM | 556099109 | $64.2K | 2,014,400 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $58.0K | 2,466,255 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $53.9K | 1,530,717 | 0.0% |
| NanoString Technologies Inc(NSTGEUR) | COM | 63009R109 | $52.8K | 804,029 | 0.0% |
| Avadel Pharmaceuticals plc | SPONSORED ADR | 05337M104 | $51.9K | 5,741,939 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $51.7K | 3,264,031 | 0.0% |
| Pulmonx Corp(LUNG) | COM | 745848101 | $51.7K | 1,129,600 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $50.1K | 1,245,532 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $48.8K | 2,652,553 | 0.0% |
| ProQR Thrapeutics N V | SHS EURO | N71542109 | $42.5K | 6,424,078 | 0.0% |